Arzestra™

Read the CMI leaflet (Opens in new tab) for facts you need to know before, during and after taking your medicine.

For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).

ARZESTRA is indicated in females of childbearing age for the medical termination of an intrauterine pregnancy, up to 63 days of gestation.,It is recommended that the duration of pregnancy (i.e., up to 63 days gestation) be confirmed by ultrasound. In the event that an ultrasound is not possible, extra caution should be exercised.,Ultrasound is also useful to exclude ectopic pregnancy.

Source: ARTG

• Shelf lifetime is 36 Months
• Store below 25 degrees Celsius
• Protect from Light; Store in Original Container

Source: ARTG

Composite pack

This medicine is a pack that contains more than one component.

Important: The components listed below are not necessarily in order of use. Please refer to the Consumer Medicine Information (CMI) or consult your doctor for proper administration instructions and sequence.

Component

• Tablet
• Oral
• Uncoated yellow, round, biconvex tablets debossed with CC12 on one side and plain on other side.

Component

• Tablet
• Buccal
• White to off white round, flat faced bevelled edge tablet debossed with C above and 15 below on one side and plain on other side

Source: ARTG

These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.?What is the medicines and poisons schedule?

All medicines and poisons in Australia are categorised by how they are made available to the public. Medicines with a low safety risk are usually less tightly controlled than medicines with a higher safety risk. This system is called ‘scheduling’. You can read more about the scheduling of medicines as well as the different scheduling categories on our Scheduling of medicines and poisons information page.

• 5 tablets (1 x Mifepristone 200 mg tablet and 4 x Misoprostol 200 micrograms tablets)

Source: ARTG

This medicine is not listed on the Pharmaceutical Benefits Scheme (PBS). Talk to your pharmacist about how much it will cost.

Source: PBS

For the active ingredients: Misoprostol, Mifepristone

This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy. Do not stop taking this medicine abruptly without medical advice, as this may cause harm to you or your baby.

Source: AHT

If you experience a side effect from this medicine, tell your doctor or pharmacist. Or report it directly to the TGA (Therapeutic Goods Administration).

You can report side effects to your doctor, or directly at Report an adverse event or safety problem (Opens in new tab)

Source: ARTG

Healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions (Opens in new tab).